Serum interleukin-18 in children with henoch-schönlein purpura: A promising marker of disease activity?

European Journal of Inflammation

Volumn 9, Issue 2, 2011, Pages 151-156

  Rigante, D ^a   Zampetti, A ^a   Bersani, G ^a   Candelli, M ^a   Piras, A ^a   Rendeli, C ^a   Antuzzi, D ^a   Feliciani, C ^a   Stabile, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Children; Henoch Sch nlein purpura; Interleukin 12; Interleukin 18; Interleukin 6

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6;

ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; MALE; PERIPHERAL EDEMA; PROGNOSIS; RELAPSE; SCHOOL CHILD; SEX;

EID: 81855211902     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900209     Document Type: Article

References (24)

1. Rostoker G. Schönlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001; 15:99-138.
2. Szer IS. Henoch-Schönlein purpura. Current science. Curr Opin Rheumatol 1994; 6:25-31.
3. Rigante D. Clinical overview of vasculitic syndromes in the pediatric age. Eur Rev Med Pharmacol Sci 2006; 10:337-45. (Pubitemid 46157451)
4. Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999; 13:816-23.
5. Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of renal involvement or relapsing disease in children with Henoch-Schönlein purpura. Rheumatol Int 2005; 25:45-88.
6. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM. The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 1997; 26:456-60.
7. Ilan Y, Naparstek Y. Schönlein-Henoch syndrome in adults and children. Semin Arthritis Rheum 1991; 21:103-09.
8. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis, and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010; 69:798-804.
9. Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schönlein purpura. Pediatr Nephrol 2005; 20:149-53.
10. Edström Hailing S, Söderberg MP, Berg UB. Predictors of outcome in Henoch-Schönlein nephritis. Pediatr Nephrol 2010; 25:1101-08.
11. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 1998; 114:468-76. (Pubitemid 28539609)
12. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007; 27:98-114.
13. Esfandiari E, McInnes IB, Lindop G, et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol 2001; 167:5338-47. (Pubitemid 33009773)
14. Liang D, Liu HF, Yao CW, et al. Effects of interleukin-18 on injury and activation of human proximal tubular epithelial cells. Nephrology 2007; 12:53-61.
15. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev 2003; 3:133-46. (Pubitemid 37328691)
16. Sato S, Hanakawa H, Hasegawa M, et al. Levels of interleukin-12, a cytokine of type 1 helper T-cells, are elevated in sera from patients with systemic sclerosis. J Rheumatol 2000; 27:2838-42.
17. Zouboulis CC. HLA-independent antibacterial host response toward Th1 immunity mediated by IL-12: a new concept for the pathogenesis of Adamantiades--Behçet's disease. J Invest Dermatol 2006; 126:1444-47.
18. Saruhan-Direskeneli G, Biçakçigil M, Yilmaz V, et al. Interleukin (IL)-12, IL-2 and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum Immunol 2006; 67:735-40. (Pubitemid 44416012)
19. Snell-Bergeon JK, West NA, Mayer-Davis EJ, et al. Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH case-control study. J Clin Endocrinol Metab 2010; 95:2868-76.
20. Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. J Microbiol Immunol Infect 2006; 39:476-82.
21. Gono T, Kawaguchi Y, Sugiura T, et al. Interleukin-18 is a key-mediator in dermatomyositis: a potential contribution to development of interstitial lung disease. Rheumatology 2010; 49:1878-81.
22. Hartford M, Wiklund O, Hultén LM, et al. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arterioscler Thrombos Vasc Biol 2010; 30:2039-46.
23. Novick D, Elbirt D, Dinarello CA, Rubinstein M, Sthoeger ZM. Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis. J Clin Immunol 2009; 29:38-45.
24. Torres O, Palomino-Morales R, Miranda-Filloy JA, Vazquez-Rodriguez TR, Martin J, Gonzalez-Gay MA. IL-18 gene polymorphisms in Henoch-Schönlein purpura. Clin Exp Rheumatol 2010; 28:114.